When given the proper team and infrastructure, low-dose CT programs excel at keeping patients on their imaging schedule, Kaiser researchers reported in JAMA. 

There were sharp declines last year in testing to diagnose breast, colorectal and prostate cancers, experts reported in JAMA Oncology. 

Shortening observation times after transthoracic biopsies and eliminating follow-up chest X-rays are both appropriate for many low-risk patients.

That’s according to a new study of traditional and open-access business models spanning radiology-focused journals, shared in Clinical Imaging.

The number of such survivors has swelled in recent years amid improvements in diagnosis and treatment, experts wrote in JACR. 

Scientists suggested restricting the time and frequency of some fluoroscopy-guided treatments to help minimize local damage, such as skin cancer in the fingers. 

The American College of Radiology alerted members about this issue Friday, steering them to an update recommending CT or MRI as part of the initial workup for patients with rare blood clotting. 

Plus, imaging provider Envision Healthcare promotes permanent chief financial officer, UCSF appoints three new clinical leaders and more.